{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:36:40Z","timestamp":1793749000113,"version":"4.6.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.nbd.2025.106986","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T12:18:59Z","timestamp":1748953139000},"page":"106986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides"],"prefix":"10.1016","volume":"213","author":[{"given":"Andrea","family":"Loreto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn M.L.","family":"Cramb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Cirilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Claudia","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Arthur-Farraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Daniel","family":"du Preez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot D.","family":"Mock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien T.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Orsomando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wade-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.106986_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103812","article-title":"SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites","volume":"25","author":"Angeletti","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.nbd.2025.106986_bb0010","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1007\/s12035-024-04480-2","article-title":"Chronically low NMNAT2 expression causes sub-lethal SARM1 activation and altered response to nicotinamide riboside in axons","volume":"62","author":"Antoniou","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2025.106986_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107044","article-title":"Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson\u2019s iPSC-dopamine neurons","volume":"26","author":"Beccano-Kelly","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.nbd.2025.106986_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00511-x","article-title":"Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients","volume":"17","author":"Bloom","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.106986_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab184","article-title":"Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy","author":"Bosanac","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106986_bb0030","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.neuron.2022.08.017","article-title":"Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease","volume":"110","author":"Bratkowski","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106986_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2018.01.012","article-title":"Identification of the nicotinamide salvage pathway as a new Toxification route for antimetabolites","volume":"25","author":"Buonvicino","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.nbd.2025.106986_bb0040","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1038\/s41467-018-06448-y","article-title":"Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa","volume":"9","author":"Buskin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2025.106986_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113636","article-title":"SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration","volume":"339","author":"Chen","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106986_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41583-020-0269-3","article-title":"Programmed axon degeneration: from mouse to mechanism to medicine","volume":"21","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2025.106986_bb0055","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1093\/brain\/awad064","article-title":"Impaired dopamine release in Parkinson\u2019s disease","volume":"146","author":"Cramb","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.106986_bb0060","series-title":"Differentiation of Human Dopamine Neurons (DaNs) from Induced Pluripotent Stem Cells (iPSCs)","author":"Cramb","year":"2023"},{"key":"10.1016\/j.nbd.2025.106986_bb0065","first-page":"15","article-title":"SARM1 depletion slows axon degeneration in a CNS model of neurotropic viral infection","author":"Crawford","year":"2022","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/j.nbd.2025.106986_bb0070","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/jcm9062004","article-title":"Antisense oligonucleotides: an emerging area in drug discovery and development","volume":"9","author":"Dhuri","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.nbd.2025.106986_bb0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/cdd.2014.164","article-title":"A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration","volume":"22","author":"Di Stefano","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2025.106986_bb0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cub.2017.01.070","article-title":"NMN Deamidase delays Wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo","volume":"27","author":"Di Stefano","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.nbd.2025.106986_bb0085","series-title":"Macrophage Depletion Blocks Congenital SARM1-Dependent Neuropathy","author":"Dingwall","year":"2022"},{"key":"10.1016\/j.nbd.2025.106986_bb0090","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3390\/ijms10041729","article-title":"Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing","volume":"10","author":"Dzeja","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2025.106986_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2017.02.022","article-title":"The SARM1 toll\/Interleukin-1 receptor domain possesses intrinsic NAD+ cleavage activity that promotes pathological axonal degeneration","volume":"93","author":"Essuman","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106986_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1158388","article-title":"SARM1 detection in myelinating glia: sarm1\/Sarm1 is dispensable for PNS and CNS myelination in zebrafish and mice","volume":"17","author":"Fazal","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2025.106986_bb0105","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1038\/s41598-017-05633-1","article-title":"Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential","volume":"7","author":"Fedele","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.106986_bb0110","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208457119","article-title":"Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain","volume":"119","author":"Feldman","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2025.106986_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2021.02.009","article-title":"SARM1 is a metabolic sensor activated by an increased NMN\/NAD+ ratio to trigger axon degeneration","volume":"109","author":"Figley","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2025.106986_bb0120","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/hmg\/ddt587","article-title":"A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis","volume":"23","author":"Fogh","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.106986_bb0125","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1084\/jem.20181040","article-title":"Gene therapy targeting SARM1 blocks pathological axon degeneration in mice","volume":"216","author":"Geisler","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2025.106986_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000300","article-title":"Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons","volume":"8","author":"Gilley","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.nbd.2025.106986_bb0135","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2015.02.060","article-title":"Absence of SARM1 rescues development and survival of NMNAT2-deficient axons","volume":"10","author":"Gilley","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106986_bb0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.celrep.2017.09.027","article-title":"Sarm1 deletion, but not WldS, confers lifelong rescue in a mouse model of severe axonopathy","volume":"21","author":"Gilley","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106986_bb0145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70905","article-title":"Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders","volume":"10","author":"Gilley","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.nbd.2025.106986_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110108","article-title":"Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration","volume":"37","author":"Gould","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106986_bb0155","article-title":"Stepwise activation of SARM1 for cell death and axon degeneration revealed by a biosynthetic NMN mimic","volume":"122","author":"Huang","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2025.106986_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108588","article-title":"Small molecule SARM1 inhibitors recapitulate the SARM1\u2212\/\u2212 phenotype and allow recovery of a metastable Pool of axons fated to degenerate","volume":"34","author":"Hughes","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106986_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.112958","article-title":"Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia","volume":"320","author":"Huppke","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106986_bb0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tips.2020.01.006","article-title":"Axons matter: the promise of treating neurodegenerative disorders by targeting SARM1-mediated axonal degeneration","volume":"41","author":"Krauss","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2025.106986_bb0175","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2025.106986_bb0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.stem.2018.10.023","article-title":"Single-cell sequencing of iPSC-dopamine neurons reconstructs disease progression and identifies HDAC4 as a regulator of Parkinson cell phenotypes","volume":"24","author":"Lang","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2025.106986_bb0185","series-title":"SARM1 Orthosteric Base Exchange Inhibitors Cause Subinhibitory SARM1 Activation","author":"Leahey","year":"2024"},{"key":"10.1016\/j.nbd.2025.106986_bb0190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198001103020202","article-title":"The neurotoxicity of the rat poison vacor","volume":"302","author":"LeWitt","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2025.106986_bb0195","article-title":"Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate","volume":"10","author":"Li","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.nbd.2025.106986_bb0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fncel.2014.00087","article-title":"Sarm1 deficiency impairs synaptic function and leads to behavioral deficits, which can be ameliorated by an mGluR allosteric modulator","volume":"8","author":"Lin","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2025.106986_bb0205","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.2147\/DDDT.S329547","article-title":"The expanding role of pyridine and Dihydropyridine scaffolds in drug design","volume":"15","author":"Ling","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.nbd.2025.106986_bb0210","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.7150\/thno.49054","article-title":"SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-\u03baB signaling","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.nbd.2025.106986_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.omtn.2023.02.029","article-title":"Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies","volume":"32","author":"Liu","year":"2023","journal-title":"Molecular Therapy - Nucleic Acids"},{"key":"10.1016\/j.nbd.2025.106986_bb0220","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80245","article-title":"The NAD+ precursor NMN activates dSarm to trigger axon degeneration in Drosophila","volume":"11","author":"Llobet Rosell","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.nbd.2025.106986_bb0225","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.celrep.2015.11.032","article-title":"Wallerian degeneration is executed by an NMN-SARM1-dependent late Ca2+ influx but only modestly influenced by mitochondria","volume":"13","author":"Loreto","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106986_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104678","article-title":"Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration","volume":"134","author":"Loreto","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2025.106986_bb0235","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72823","article-title":"Neurotoxin-mediated \u00ad\u00adpotent activation of the axon degeneration regulator SARM1","volume":"10","author":"Loreto","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.nbd.2025.106986_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2023.01.004","article-title":"NMN: the NAD precursor at the intersection between axon degeneration and anti-ageing therapies","author":"Loreto","year":"2023","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2025.106986_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.112961","article-title":"Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence","volume":"320","author":"Lukacs","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106986_bb0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tins.2021.10.014","article-title":"Mitochondrial dysfunction as a trigger of programmed axon death","volume":"45","author":"Merlini","year":"2022","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2025.106986_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113939","article-title":"Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues","volume":"9","author":"Mori","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.nbd.2025.106986_bb0260","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1223899","article-title":"dSarm\/Sarm1 is required for activation of an injury-induced axon death pathway","volume":"337","author":"Osterloh","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.nbd.2025.106986_bb0265","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ng.3622","article-title":"Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis","volume":"48","author":"van Rheenen","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2025.106986_bb0270","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2025.106986_bb0275","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1523\/JNEUROSCI.5469-08.2009","article-title":"Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide","volume":"29","author":"Sasaki","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106986_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113252","article-title":"cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons","author":"Sasaki","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2025.106986_bb0285","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161566","article-title":"A SARM1-mitochondrial feedback loop drives neuropathogenesis in a Charcot-Marie-tooth disease type 2A rat model","volume":"132","author":"Sato-Yamada","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2025.106986_bb0290","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.molcel.2022.03.007","article-title":"Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules","volume":"82","author":"Shi","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.nbd.2025.106986_bb0295","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1523\/JNEUROSCI.0877-14.2014","article-title":"Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons","volume":"34","author":"Summers","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2025.106986_bb0300","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s13238-021-00835-w","article-title":"Sarm1-mediated neurodegeneration within the enteric nervous system protects against local inflammation of the colon","volume":"12","author":"Sun","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.nbd.2025.106986_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008343","article-title":"Novel role of SARM1 mediated axonal degeneration in the pathogenesis of rabies","volume":"16","author":"Sundaramoorthy","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2025.106986_bb0310","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/nar\/gkl1071","article-title":"Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals","volume":"35","author":"Swayze","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2025.106986_bb0315","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1128\/JVI.00836-09","article-title":"The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile virus pathogenesis","volume":"83","author":"Szretter","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2025.106986_bb0320","series-title":"SARM1 Activation Promotes Axonal Degeneration Via a Two-Step Liquid-to-Solid Phase Transition","author":"Wenbin","year":"2024"},{"key":"10.1016\/j.nbd.2025.106986_bb0325","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1093\/hmg\/ddad102","article-title":"Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson\u2019s disease models","volume":"32","author":"Williamson","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.106986_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109872","article-title":"Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss","volume":"37","author":"Wu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.106986_bb0335","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40478-024-01736-9","article-title":"Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucoma","volume":"12","author":"Zeng","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2025.106986_bb0340","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.isci.2019.05.001","article-title":"A Cell-permeant mimetic of NMN activates SARM1 to produce cyclic ADP-Ribose and induce non-apoptotic Cell Death","volume":"15","author":"Zhao","year":"2019","journal-title":"iScience"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T20:46:01Z","timestamp":1758833161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125002025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":68,"alternative-id":["S0969996125002025"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106986","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.02.587827","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.106986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106986"}}